Challenges and opportunities: what we are learning from the clinical natalizumab experience.
about
Challenges and opportunities: what we are learning from the clinical natalizumab experience.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Challenges and opportunities: ...... inical natalizumab experience.
@ast
Challenges and opportunities: ...... inical natalizumab experience.
@en
type
label
Challenges and opportunities: ...... inical natalizumab experience.
@ast
Challenges and opportunities: ...... inical natalizumab experience.
@en
prefLabel
Challenges and opportunities: ...... inical natalizumab experience.
@ast
Challenges and opportunities: ...... inical natalizumab experience.
@en
P2860
P356
P1476
Challenges and opportunities: ...... inical natalizumab experience.
@en
P2093
Norman J Kachuck
P2860
P304
P356
10.1586/14737175.5.5.605
P577
2005-09-01T00:00:00Z